Biocon Q1 preview: Net profit seen rising 44% on last year#39;s low base

Biocon Q1 preview: Net profit seen rising 44% on last year#39;s low base The company#39;s performance in the June quarter is also expected to augmented by the performance of its biologics, branded formulations and research services segments

No comments:

Post a Comment